Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.61
- Piotroski Score 6.00
- Grade Sector Weight
- Symbol (AVNS)
- Company Avanos Medical, Inc.
- Price $18.02
- Changes Percentage (0.84%)
- Change $0.15
- Day Low $17.84
- Day High $18.37
- Year High $25.36
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/18/2025
- Fiscal Year End N/A
- Average Stock Price Target $23.00
- High Stock Price Target $26.00
- Low Stock Price Target $20.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.03
- Trailing P/E Ratio -658.67
- Forward P/E Ratio -658.67
- P/E Growth -658.67
- Net Income $-61,800,000
Income Statement
Quarterly
Annual
Latest News of AVNS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Is Avanos Medical, Inc.'s (NYSE:AVNS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Avanos Medical's stock has surged by 27% in the last three months. Analyzing its Return on Equity (ROE) reveals a low 0.6%, below the industry average....
By Yahoo! Finance | 2 months ago -
Avanos Medical (NYSE:AVNS) investors are sitting on a loss of 44% if they invested five years ago
Avanos Medical, Inc. (NYSE:AVNS) shares have recently gained 27%, but are still down 44% over the last five years. Despite revenue stability, profitability remains uncertain. Investors are advised to ...
By Yahoo! Finance | 3 months ago
